Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with

J C Chambers1, A McGregor, J Jean-Marie

  • 1National Heart and Lung Institute, Imperial College School of Medicine, Hammersmith Hospital, London, UK.

Circulation
|March 9, 1999
PubMed

Insights

Elevated homocysteine levels acutely impair vascular endothelial function, a process linked to oxidative stress. Vitamin C pretreatment prevents this dysfunction in healthy individuals, suggesting a protective role against homocysteine-induced vascular damage.

Area of Science:

  • Cardiovascular Research
  • Vascular Biology
  • Nutritional Science

Background:

  • Hyperhomocysteinemia is a significant risk factor for vascular disease.
  • The precise mechanisms by which homocysteine contributes to atherosclerosis remain unclear.
  • Oxidative stress is implicated in homocysteine-mediated endothelial dysfunction.

Purpose of the Study:

  • To investigate the association between elevated homocysteine concentrations and acute endothelial dysfunction.
  • To determine if vitamin C can prevent homocysteine-induced endothelial dysfunction.
  • To explore the role of oxidant stress mechanisms in this process.

Main Methods:

  • 17 healthy volunteers underwent oral L-methionine challenge to induce hyperhomocysteinemia.
  • Brachial artery diameter responses (endothelium-dependent and independent) were measured using high-resolution ultrasound.
  • Measurements were taken at baseline, 2, and 4 hours post-methionine, with and without vitamin C pretreatment.

Main Results:

  • Oral L-methionine significantly increased plasma homocysteine levels and reduced flow-mediated dilatation.
  • A strong inverse correlation was observed between homocysteine concentration and flow-mediated dilatation.
  • Vitamin C pretreatment did not alter homocysteine levels but significantly ameliorated the reduction in flow-mediated dilatation.

Conclusions:

  • Acute elevation of homocysteine impairs vascular endothelial function in healthy subjects.
  • Vitamin C pretreatment effectively prevents this acute endothelial dysfunction.
  • These findings support the hypothesis that homocysteine exerts adverse vascular effects via oxidative stress mechanisms.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...